FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrockets
February 18, 2022 at 18:09 PM EST
The FDA in November temporarily put the brakes on Ocugen's plan to test Covaxin in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.